Seeing Is Believing
EFTR is currently covered by 3 analysts with an average price target of $9.88. This is a potential upside of $9.88 (0%) from yesterday's end of day stock price of $0.
Effector Therapeutics's activity chart (see below) currently has 12 price targets and 20 ratings on display. The stock rating distribution of EFTR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 235.6 days.
Highest price target for EFTR is $1, Lowest price target is $1, average price target is $9.88.
Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-May-2023. First documented stock forecast 13-Sep-2021.
Currently out of the existing stock ratings of EFTR, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$1.3
$0.13 (11.11%)
1 years 6 months 28 days ago
(26-May-2023)
1/3 (33.33%)
$0.64 (96.97%)
11
Buy
1 years 7 months 14 days ago
(10-May-2023)
2/3 (66.67%)
$9.66 (222.58%)
740
Buy
$1
$-0.17 (-14.53%)
$2
1 years 11 months 15 days ago
(09-Jan-2023)
3/4 (75%)
$0.6 (150.00%)
427
Buy
2 years 6 months 18 days ago
(06-Jun-2022)
0/2 (0%)
$30.7 (159.07%)
Buy
2 years 8 months 20 days ago
(04-Apr-2022)
0/1 (0%)
$7.79 (63.80%)
What is EFTR (Effector Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on EFTR (Effector Therapeutics) with a proven track record?
Which analyst has the current lower performing score on EFTR (Effector Therapeutics) with a proven track record?
Which analyst has the most public recommendations on EFTR (Effector Therapeutics)?
Which analyst is the currently most bullish on EFTR (Effector Therapeutics)?
Which analyst is the currently most reserved on EFTR (Effector Therapeutics)?